YOLFTbeta
Plant Advanced Technologies SA

Plant Advanced Technologies SA

ALPAT · PA · Healthcare / Biotechnology

3.98EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close3.98
Open3.98
Day Range3.98 – 3.98
52-Week Range3.82 – 8.94
Volume220
Market Cap4.44M
P/E (TTM)7.65
Forward P/E0.00
EPS0.51
Dividend Yield0.00%
Beta0.82
50-Day Avg4.38
200-Day Avg6.45

About

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vand"uvre-lès-Nancy, France.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jean-Paul Fevre
  • Employees11
  • Headquarters19 Avenue de la forEt de Haye, Vand?uvre-lès-Nancy, France, 54500, France
  • Websitehttps://www.plantadvanced.com

Leadership

  • Mr. Jean-Paul FevreChairman & CEO · b. 1954
  • Dr. Frederic BourgaudDirector, Deputy CEO & VP of Research · b. 1964

Financials

Income Statement

Currency: EUR2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue81.00K85.50K96.00K151.08K213.91K917.00K1.21M1.68K1.88K1.58K1.46K1.87K1.17M1.72M2.31M2.34M1.68M1.93M1.14M
Growth (%)-+5.56%+12.28%+57.38%+41.59%+328.68%+31.57%-99.86%+11.63%-16.10%-7.27%+28.04%+62534.54%+46.57%+34.09%+1.48%-28.11%+14.61%-40.95%
Cost of Revenue8.00K188.67K304.03K539.54K709.72K-437.92K-415.62K1.07K1.15K861.11865.911.23K2.43M4.54M5.03M6.99M-471.40K-308.33K1.83M
Gross Profit--103.17K-208.03K-388.46K-495.81K1.35M1.62M615.76730.23716.01596.48640.85-1.26M-2.82M-2.73M-4.65M2.15M2.24M-693.73K
Gross Margin--120.67%-216.70%-257.12%-231.78%147.76%134.45%36.57%38.85%45.40%40.79%34.22%-107.47%-164.22%-118.31%-198.89%128.03%116.00%-60.97%
Operating Expense-12.69K2.52K20.34K-23.68K1.52M2.03M1.70K2.08K2.56K2.46K2.76K251.98K23.00K310.00K-2.79M2.93M2.02M0
Operating Income--115.86K-210.55K-408.80K-472.13K-163.66K-409.23K-1.08K-1.35K-1.84K-1.87K-2.11K-1.51M-2.85M-3.04M-1.86M-778.24K214.97K-693.73K
Operating Margin--135.51%-219.32%-270.58%-220.71%-17.85%-33.92%-64.26%-72.03%-116.79%-127.65%-112.95%-128.95%-165.56%-131.76%-79.61%-46.28%11.15%-60.97%
EBITDA--12.72K-99.68K-96.85K14.49K136.67K-73.48K-674.89K-702.02K-1.28M-1.01M681.53K-854.12K-819.00K-1.27M-744.00K72.53K956.45K-693.73K
EBITDA Margin--14.88%-103.84%-64.11%6.77%14.90%-6.09%-40076.60%-37345.95%-80892.32%-68840.39%36397.43%-72.83%-47.64%-54.92%-31.81%4.31%49.63%-60.97%
Net Income-1.92K-43.94K-33.38K25.90K259.34K-66.03K-594.63-894.93-1.13K-674.79864.51-541.23K-543.00K-1.13M-849.00K79.17K935.13K569.40K
Net Income Margin-2.25%-45.77%-22.09%12.11%28.28%-5.47%-35.31%-47.61%-71.36%-46.14%46.17%-46.15%-31.59%-49.20%-36.30%4.71%48.52%50.04%
R&D------836.00K------------
R&D as % of Total Revenue------69.29%------------
Interest Expense012.99K7.58K6.59K12.46K15.62K33.80K67.66K79.75K81.25K62.37K92.87K84.60K112.00K115.00K107.00K112.72K106.69K143.86K
Interest Expense % of Total Revenue0.00%15.19%7.89%4.36%5.82%1.70%2.80%4017.70%4242.54%5151.73%4265.21%4959.81%7.21%6.52%4.99%4.57%6.70%5.54%12.64%

Balance Sheet

Currency: EUR2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets529.89K1.02M3.22M2.88M3.54M4.26M5.51K10.44K9.80K9.80K12.71K13.89M17.27M17.11M17.08M14.91M16.00M16.37M
Total Liabilities367.61K450.24K971.10K805.33K1.39M2.16M3.15K2.73K3.21K3.39K4.35K3.88M8.73M9.73M10.29M6.78M6.83M6.53M
Total Equity162.28K571.54K1.77M1.80M2.15M2.10M2.35K7.71K6.59K6.41K8.36K10.00M7.53M6.36M5.50M8.13M9.17M9.84M
Cash65.64K300.63K1.27M190.58K19.33K63.67K91.073.22K1.23K43.14657.311.53M3.26M2.49M669.00K-79.70K55.00K
Total Debt227.34K213.70K192.15K211.13K162.81K1.43M2.29M2.06M1.93M2.23M3.24M2.94M5.73M6.14M5.97M4.36M3.42M3.62M
Net Debt161.70K-86.93K-1.07M20.55K143.48K1.36M2.29M2.06M1.93M2.23M3.24M1.41M2.47M3.65M5.30M4.36M3.34M3.57M

Cash Flow

Currency: EUR2009-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-283.05K160.93K-559-1.22K6012878.00K810.09K78-388-2741.85M2.50M-
Investing Cash Flow--404.38K-1.49M-1.13K-1.66K-1.93K-2.11K-1.18M-1.18M-1.18K-1.11K-1.97K-1.28M-1.59M-
Financing Cash Flow453.00K-30.88K1.01M1.84K5.98K1607512.38M2.38M2.38K743244-851.03K-585.89K-
Capital Expenditure180.00K353.49K1.35M6767221.21K753577.00K577.00K577116205875.62K412.42K0
Free Cash Flow--70.44K-1.19M-1.24K-1.95K-1.15K-625-810.09K-499-504-479972.53K2.08M-
FCF to OCF--24.89%-739.46%220.93%158.99%-1915.00%-488.28%-100.00%-639.74%129.90%174.82%52.62%83.48%-

Earnings

Report DateFeb 3, 2016Oct 27, 2016Apr 27, 2017Oct 19, 2017Apr 13, 2018Oct 30, 2018May 1, 2019Oct 28, 2019Aug 6, 2020Oct 30, 2020Apr 30, 2021Oct 28, 2021May 2, 2022Nov 2, 2022May 3, 2023Nov 1, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00
EPS Actual-0.31-1.410.16-0.68-0.07-0.501.29-0.48-0.06-0.660.04-0.99-0.05-0.970.18-0.14
Surprise----------------
Timing-Pre-marketPre-marketAfter-hoursPre-market--After-hoursPre-marketPre-market-After-hoursAfter-hoursPre-marketAfter-hours-

Key Statistics & Ratios

Market Cap4.44M
Enterprise Value12.92M
Trailing P/E7.65
Forward P/E0.00
Price / Sales3.24
Price / Book1.03
EPS0.51
Book Value8.75
Revenue (TTM)1.37M
Gross Profit (TTM)807.86K
EBITDA219.85K
Profit Margin41.54%
Operating Margin8.34%
Return on Equity5.85%
Return on Assets-1.40%
Shares Outstanding1.14M
Shares Float613.47K
Beta0.82
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%